Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 130-139

  Bonaccorsi, Irene ^a   Altieri, Fabio ^b   Sciamanna, Ilaria ^c   Oricchio, Elisa ^c   Grillo, Caterina ^b   Contartese, Giuseppe ^a   Galati, Enza Maria ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Differentiation; Human tumor cell; Proliferation; Reverse transcriptase; Ursolic acid

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TRITERPENOID; URSOLIC ACID;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FIBROBLAST; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; ION EXCHANGE CHROMATOGRAPHY; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-DIRECTED DNA POLYMERASE; TRITERPENES;

EID: 41049100978     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.026     Document Type: Article

References (32)

1. Dorai T., and Aggarwal B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett. 25 (2004) 129-140
2. Ovesná Z., Vachálková A., Horváthová K., and Tothová D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview, Neoplasma 51 (2004) 327-334
3. Aggarwal B.B., and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 14 (2006) 1397-1421
4. Liu J. Pharmacology of oleanolic and ursolic acid. J. Ethnopharmacol. 49 (1995) 57-68
5. Es-saady D., Simon A., Ollier M., Maurizis J.C., Chulia A.J., and Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett. 10 (1996) 193-197
6. Li J., Guo W.J., and Yang Q.Y. Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. World J. Gastroenterol. 8 (2002) 93-495
7. Hsu Y.L., Kuo P.L., and Lin C.C. Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci. 75 (2004) 2303-2316
8. Ovesná Z., and Slamenova D. Protective effects of ursolic acid and oleanolic acid in leukemic cells. Mutat. Res. (2006) 131-137
9. Kassi E., Papoutsi Z., Pratsinis H., Aligiannis N., Manoussakis M., and Moutsatsou P. Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cells. J. Cancer. Res. Clin. Oncol. 133 (2007) 493-500
10. Tokuda H., Ohigashi H., Koshimizu K., and Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetredecanoyl-phrbol-13-acetate. Cancer Lett. 33 (1986) 279-285
11. Sohn K.H., Lee H.Y., Chung H.Y., Young H.S., Yi S.Y., and Kim K.W. Anti-angiogenic activity of triterpene acids. Cancer Lett. 94 (1995) 213-218
12. Novotný L., Yachalkova A., and Biggs D. Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview, Neoplasma 48 (2001) 241-246
13. Yim E.K., Namkoong K., Um S.J., and Park J.S. Proteomic analysis of ursolic acid-induced apoptosis in cervical carcinoma cells. Cancer Lett. 235 (2006) 209-220
14. Lee H.Y., Chung H.Y., Kim K.H., Lee J.J., and Kim K.W. Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol. 120 (1994) 513-518
15. Sinibaldi-Vallebona P., Lavia P., Garaci E., and Spadafora C. A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy. Gene Chromosomes Canc. 45 (2006) 1-10
16. Sciamanna I., Landriscina M., Pittoggi C., Quirino M., Mearelli C., Beraldi R., Mattei E., Serafino A., Cassano A., Sinibaldi-Vallebona P., Garaci E., Barone C., and Spadafora C. Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 24 (2005) 3923-3931
17. Sauane M., Gopalkrishnan R.V., Sarkar D., Su Z.Z., Lebedeva I.V., Dent P., Pestka S., and Fisher P.B. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14 (2003) 35-51
18. Landriscina M., Fabiano A., Altamura S., Bagalà C., Piscazzi A., Cassano A., Spadafora C., Giorgino F., Barone C., and Cignarelli M. Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma. J. Clin. Endocr. Metab. 90 (2005) 5663-5671
19. Hoffman L., Brooks S.E., Stein M.R., and Schneck L. Cyclic AMP causes differentiation and decreases the expression of neutral glycosphingolipids in cell cultures derived from a malignant glioma. Biochim. Biophys. Acta 26 (1994) 37-44
20. Pittoggi C., Sciamanna I., Mattei E., Beraldi R., Lobascio A.M., Mai A., Quaglia M.G., Lorenzini R., and Spadafora C. Role of Endogenous reverse transcriptase in murine early embryo development. Mol. Reprod. Dev. 66 (2003) 225-236
21. Pyra H., Boni J., and Schupbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc. Natl. Acad. Sci. USA 91 (1994) 1544-1548
22. Di Marzo Veronese F., Copeland T.D., DeVico A.L., Rahman R., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231 (1986) 1289-1291
23. Ostertag E.M., and Kazazian H.H. Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res. 11 (2001) 2059-2065
24. Leszczyniecka M., Roberts T., Dent P., Grant S., and Fisher P.B. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther. 90 (2001) 105-156
25. Mizushina Y., Iida A., Ohta K., Sugawara F., and Sakaguchi K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem. J. 15 (2000) 757-763
26. Akihisa T., Ogihara J., Kato J., Yasukawa K., Ukiya M., Yamanouchi S., and Oishi K. Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase. Lipids 36 (2001) 507-512
27. Martin S.L. Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol. Cell Biol. 11 (1991) 4804-4807
28. Deragon J.M., Sinnett D., and Labuda D. Reverse transcriptase activity from human embryonal carcinoma cells NTera2D1. EMBO J. 9 (1990) 3363-3368
29. Martin S.L., and Branciforte D. Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol. Cell Biol. 13 (1993) 5383-5392
30. Mangiacasale R., Pittoggi C., Sciamanna I., Careddu A., Mattei E., Lorenzini R., Travaglino L., Landriscina M., Barone C., Nervi C., Lavia P., and Spadafora C. Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiation. Oncogene 22 (2003) 2750-2761
31. Oricchio E., Sciamanna I., Beraldi R., Tolstonog G.V., Schumann G.G., and Spadafora C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 26 (2007) 4226-4233
32. Spadafora C. Endogenous reverse transcriptase: a mediator of cell proliferation and differentiation. Cytogenet. Genome Res. 105 (2004) 346-350